Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neurodegenerative Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neurodegenerative Diseasemarket, defines the market attractiveness level of Neurodegenerative Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neurodegenerative Disease industry, describes the types of Neurodegenerative Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neurodegenerative Disease market and the development prospects and opportunities of Neurodegenerative Disease industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neurodegenerative Disease market in Chapter 13.
By Player:
Novartis
Pfizer
GlaxoSmithKline
TEVA
UCB
Sanofi
Boehringer Ingelheim
Biogen Idec
Merck Serono
By Type:
NMDA
SSRIs
Dopamine Inhibitors
By End-User:
Parkinson’s Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neurodegenerative Disease Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neurodegenerative Disease Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neurodegenerative Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neurodegenerative Disease Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neurodegenerative Disease Market Analysis and Outlook to 2022
-
7.1 Global Neurodegenerative Disease Consumption (2017-2022)
-
7.2 United States Neurodegenerative Disease Consumption (2017-2022)
-
7.3 Europe Neurodegenerative Disease Consumption (2017-2022)
-
7.4 China Neurodegenerative Disease Consumption (2017-2022)
-
7.5 Japan Neurodegenerative Disease Consumption (2017-2022)
-
7.6 India Neurodegenerative Disease Consumption (2017-2022)
-
7.7 South Korea Neurodegenerative Disease Consumption (2017-2022)
8 Region and Country-wise Neurodegenerative Disease Market Analysis and Outlook to 2028
-
8.1 Global Neurodegenerative Disease Consumption Forecast (2022-2028)
-
8.2 United States Neurodegenerative Disease Consumption Forecast (2022-2028)
-
8.3 Europe Neurodegenerative Disease Consumption Forecast (2022-2028)
-
8.4 China Neurodegenerative Disease Consumption Forecast (2022-2028)
-
8.5 Japan Neurodegenerative Disease Consumption Forecast (2022-2028)
-
8.6 India Neurodegenerative Disease Consumption Forecast (2022-2028)
-
8.7 South Korea Neurodegenerative Disease Consumption Forecast (2022-2028)
9 Global Neurodegenerative Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Neurodegenerative Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global NMDA Consumption and Growth Rate (2017-2022)
-
9.1.2 Global SSRIs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dopamine Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Neurodegenerative Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Parkinson’s Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Huntington Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Amyotrophic Lateral Sclerosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Alzheimer’s Disease Consumption and Growth Rate (2017-2022)
10 Global Neurodegenerative Disease Market Outlook by Types and Applications to 2028
-
10.1 Global Neurodegenerative Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global NMDA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global SSRIs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dopamine Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neurodegenerative Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Parkinson’s Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Huntington Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Amyotrophic Lateral Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Alzheimer’s Disease Consumption Forecast and Growth Rate (2022-2028)
11 Global Neurodegenerative Disease Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neurodegenerative Disease Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neurodegenerative Disease Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neurodegenerative Disease Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neurodegenerative Disease Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Neurodegenerative Disease Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Neurodegenerative Disease Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Neurodegenerative Disease Product and Service
-
14.4 TEVA
-
14.4.1 TEVA Company Details
-
14.4.2 TEVA Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 TEVA Neurodegenerative Disease Product and Service
-
14.5 UCB
-
14.5.1 UCB Company Details
-
14.5.2 UCB Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 UCB Neurodegenerative Disease Product and Service
-
14.6 Sanofi
-
14.6.1 Sanofi Company Details
-
14.6.2 Sanofi Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi Neurodegenerative Disease Product and Service
-
14.7 Boehringer Ingelheim
-
14.7.1 Boehringer Ingelheim Company Details
-
14.7.2 Boehringer Ingelheim Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Boehringer Ingelheim Neurodegenerative Disease Product and Service
-
14.8 Biogen Idec
-
14.8.1 Biogen Idec Company Details
-
14.8.2 Biogen Idec Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Biogen Idec Neurodegenerative Disease Product and Service
-
14.9 Merck Serono
-
14.9.1 Merck Serono Company Details
-
14.9.2 Merck Serono Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Serono Neurodegenerative Disease Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neurodegenerative Disease
-
Figure Neurodegenerative Disease Picture
-
Table Global Neurodegenerative Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurodegenerative Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurodegenerative Disease Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neurodegenerative Disease Consumption by Country (2017-2022)
-
Figure United States Neurodegenerative Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Neurodegenerative Disease Consumption and Growth Rate (2017-2022)
-
Figure China Neurodegenerative Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Neurodegenerative Disease Consumption and Growth Rate (2017-2022)
-
Figure India Neurodegenerative Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neurodegenerative Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Neurodegenerative Disease Consumption Forecast by Country (2022-2028)
-
Figure United States Neurodegenerative Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neurodegenerative Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neurodegenerative Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neurodegenerative Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neurodegenerative Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neurodegenerative Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NMDA Consumption and Growth Rate (2017-2022)
-
Figure Global SSRIs Consumption and Growth Rate (2017-2022)
-
Figure Global Dopamine Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson’s Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Huntington Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Amyotrophic Lateral Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer’s Disease Consumption and Growth Rate (2017-2022)
-
Figure Global NMDA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SSRIs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dopamine Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parkinson’s Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Huntington Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amyotrophic Lateral Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alzheimer’s Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neurodegenerative Disease Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neurodegenerative Disease Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Neurodegenerative Disease Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neurodegenerative Disease Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Neurodegenerative Disease Product and Service
-
Table TEVA (Foundation Year, Company Profile and etc.)
-
Table TEVA Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Neurodegenerative Disease Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Neurodegenerative Disease Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Neurodegenerative Disease Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Neurodegenerative Disease Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Neurodegenerative Disease Product and Service
-
Table Merck Serono (Foundation Year, Company Profile and etc.)
-
Table Merck Serono Neurodegenerative Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Serono Neurodegenerative Disease Product and Service
-
